Health state utilities associated with hyperphagia: Data for use in cost-utility models

被引:0
|
作者
Howell, Timothy A. [1 ,8 ]
Matza, Louis S. [1 ]
Mallya, Usha G. [2 ]
Goldstone, Anthony P. [3 ,4 ]
Butsch, W. Scott [5 ]
Lazarus, Ethan [6 ,7 ]
机构
[1] Evidera, Patient Ctr Res, Bethesda, MD USA
[2] Rhythm Pharmaceut Inc, Value & Evidence, Boston, MA USA
[3] Imperial Coll London, Dept Brain Sci, Div Psychiat, PsychoNeuroEndocrinol Res Grp, London, England
[4] Hammersmith Hosp, Imperial Coll Healthcare NHS Trust, Dept Endocrinol, London, England
[5] Cleveland Clin, Bariatr & Metab Inst, Cleveland Hts, OH USA
[6] Clin Nutr Ctr, Greenwood Village, CO USA
[7] Univ Colorado, Dept Family Med, Sch Med, Aurora, CO USA
[8] Evidera, Patient Ctr Res, 7101 Wisconsin Ave,Ste 1400, Bethesda, MD 20814 USA
来源
OBESITY SCIENCE & PRACTICE | 2023年 / 9卷 / 04期
关键词
health state utilities; hyperphagia; obesity; time trade-off; QUALITY-OF-LIFE; PRADER-WILLI-SYNDROME; OBESITY; OVERWEIGHT; SIBLINGS;
D O I
10.1002/osp4.652
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectiveRare genetic diseases of obesity typically present with hyperphagia, a pathologic desire to consume food. Cost-utility models assessing the value of treatments for these rare diseases will require health state utilities representing hyperphagia. This study estimated utilities associated with various hyperphagia severity levels. MethodsFour health state vignettes were developed using published literature and clinician input to represent various severity levels of hyperphagia. Utilities were estimated for these health states in a time trade-off elicitation study in a UK general population sample. ResultsIn total, 215 participants completed interviews (39.5% male; mean age 39.1 years). Mean (SD) utilities were 0.98 (0.02) for no hyperphagia, 0.91 (0.10) for mild hyperphagia, 0.70 (0.30) for moderate hyperphagia, and 0.22 (0.59) for severe hyperphagia. Mean (SD) disutilities were -0.08 (0.10) for mild, -0.28 (0.30) for moderate, and -0.77 (0.58) for severe hyperphagia. ConclusionsThese data show increasing severity of hyperphagia is associated with decreased utility. Utilities associated with severe hyperphagia are similar to those of other health conditions severely impacting quality of life (QoL). These findings highlight that treatments addressing substantial QoL impacts of severe hyperphagia are needed. Utilities estimated here may be useful in cost-utility models of treatments for rare genetic diseases of obesity.
引用
收藏
页码:376 / 382
页数:7
相关论文
共 50 条
  • [41] DISCREPANCY IN HEALTH STATE UTILITY VALUES BETWEEN COST-UTILITY ANALYSIS AND REFERENCED ORIGINAL HEALTH UTILITY STUDIES IN CARDIOVASCULAR DISEASE: A REGISTRY-BASED ANALYSIS
    Zhou, T.
    Chen, Z.
    Li, H.
    Xie, F.
    VALUE IN HEALTH, 2019, 22 : S922 - S922
  • [42] Measuring health preferences for use in cost-utility and cost-benefit analyses of interventions in children - Theoretical and methodological considerations
    Prosser, Lisa A.
    Hammitt, James K.
    Keren, Ron
    PHARMACOECONOMICS, 2007, 25 (09) : 713 - 726
  • [43] Towards Transparency in the Selection of Published Health Utility Inputs in Cost-Utility Analyses: The Health Utility Application Tool (HAT)
    Michael J. Zoratti
    Kelvin K. W. Chan
    Don Husereau
    Murray Krahn
    Mitchell Levine
    Lehana Thabane
    Feng Xie
    PharmacoEconomics, 2021, 39 : 1075 - 1084
  • [44] Towards Transparency in the Selection of Published Health Utility Inputs in Cost-Utility Analyses: The Health Utility Application Tool (HAT)
    Zoratti, Michael J.
    Chan, Kelvin K. W.
    Husereau, Don
    Krahn, Murray
    Levine, Mitchell
    Thabane, Lehana
    Xie, Feng
    PHARMACOECONOMICS, 2021, 39 (09) : 1075 - 1084
  • [45] Constructing Indirect Utility Models: Some Observations on the Principles and Practice of Mapping to Obtain Health State Utilities
    McCabe, Christopher
    Edlin, Richard
    Meads, David
    Brown, Chantelle
    Kharroubi, Samer
    PHARMACOECONOMICS, 2013, 31 (08) : 635 - 641
  • [46] Constructing Indirect Utility Models: Some Observations on the Principles and Practice of Mapping to Obtain Health State Utilities
    Christopher McCabe
    Richard Edlin
    David Meads
    Chantelle Brown
    Samer Kharroubi
    PharmacoEconomics, 2013, 31 : 635 - 641
  • [47] COST-UTILITY IN PRACTICE - A POLICY MAKERS GUIDE TO THE STATE-OF-THE-ART
    GERARD, K
    HEALTH POLICY, 1992, 21 (03) : 249 - 279
  • [48] The cost-effectiveness of oral health interventions: A systematic review of cost-utility analyses
    Hettiarachchi, Ruvini M.
    Kularatna, Sanjeewa
    Downes, Martin J.
    Byrnes, Joshua
    Kroon, Jeroen
    Lalloo, Ratilal
    Johnson, Newell W.
    Scuffham, Paul A.
    COMMUNITY DENTISTRY AND ORAL EPIDEMIOLOGY, 2018, 46 (02) : 118 - 124
  • [49] Cost-utility analysis of shoulder arthroplasty: A Swiss health economic study
    Glanzmann, Michael
    Grobet, Cecile
    Eichler, Klaus
    Meier, Flurina
    Rickenbacher, Dominik
    Brunner, Beatrice
    Audige, Laurent
    SWISS MEDICAL WEEKLY, 2019, 149 : 2S - 2S
  • [50] Economic evaluation of mental health interventions: an introduction to cost-utility analysis
    Luyten, Jeroen
    Naci, Huseyin
    Knapp, Martin
    EVIDENCE-BASED MENTAL HEALTH, 2016, 19 (02) : 49 - 53